What is Esperion Therapeutics's net debt?

Esperion Therapeutics (ESPR) reported net debt of -$924K in Q1 2026.

How has Esperion Therapeutics's net debt changed year-over-year?

Esperion Therapeutics's net debt decreased by 102.9% year-over-year, from $31.61M to -$924K.

What is the long-term trend for Esperion Therapeutics's net debt?

Over 5 years (2020 to 2025), Esperion Therapeutics's net debt has grown at a -46.7% compound annual growth rate (CAGR), from -$298.92M to -$12.88M.

What does net debt mean?

Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.

Esperion Therapeutics ESPR Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot CorporationCBT

1.1×-0.3×

Travel + LeisureTNL

6×+1.6×

UnifirstUNF

-0.2×-0.1×

HES

Hess MidstreamHESM

3.1×-0.1×

Dave, Inc.DAVE

-0.6×-1.0×

TDA

USA TODAY Co., Inc.TDAY

8.8×+4.2×

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

$155.2Mtotal debt−$156.2Mcash and equivalents=-$924K

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's net debt?: Esperion Therapeutics (ESPR) reported net debt of -$924K in Q1 2026.
How has Esperion Therapeutics's net debt changed year-over-year?: Esperion Therapeutics's net debt decreased by 102.9% year-over-year, from $31.61M to -$924K.
What is the long-term trend for Esperion Therapeutics's net debt?: Over 5 years (2020 to 2025), Esperion Therapeutics's net debt has grown at a -46.7% compound annual growth rate (CAGR), from -$298.92M to -$12.88M.
What does net debt mean?: Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.